Gender Differences in Risk Factors for Aberrant Prescription Opioid Use
To access this article, please choose from the options below
Supported in part by grants (DA015617, Dr Butler; K23 DA020681, Dr Wasan; and R21 DA024298, Dr Jamison) from the National Institute on Drug Abuse, from the National Institutes of Health, Bethesda, Maryland, and the Arthritis Foundation (Investigator Award, Dr Wasan).
PII: S1526-5900(09)00690-7
doi:10.1016/j.jpain.2009.07.016
© 2010 American Pain Society. Published by Elsevier Inc. All rights reserved.
